|
WO2011119925A2
(en)
*
|
2010-03-25 |
2011-09-29 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses for treatment of cancers
|
|
GB201006405D0
(en)
*
|
2010-04-16 |
2010-06-02 |
Isis Innovation |
Poxvirus expression system
|
|
JP2015523412A
(en)
*
|
2012-07-30 |
2015-08-13 |
ワウ ヒン イェウング，アレックス |
Live in vivo tumor-specific cancer vaccine system made by co-administration of at least two or all three components such as tumor cells, oncolytic viral vectors with transgenic expression of GM-CSF, and immune checkpoint modulators
|
|
ES2861450T3
(en)
|
2015-07-20 |
2021-10-06 |
Virttu Biologics Ltd |
Use of oncolytic herpes simplex virus in combination with an immune checkpoint inhibitor, in the treatment of cancer
|
|
BR112018013930A2
(en)
|
2016-01-08 |
2018-12-11 |
Replimune Limited |
oncolytic virus, virus expressing three heterologous genes, pharmaceutical composition, virus for use, manufacturing product, cancer treatment method, and virus use
|
|
JP7208492B2
(en)
|
2016-03-10 |
2023-01-19 |
シージー オンコロジー， インコーポレイテッド |
Methods of treating solid tumors or lymphoid tumors with combination therapy
|
|
MA43552A
(en)
|
2016-04-15 |
2018-11-07 |
Alpine Immune Sciences Inc |
CD80 VARIANT IMMUNOMODULATOR PROTEINS AND THEIR USES
|
|
EP3442999A2
(en)
|
2016-04-15 |
2019-02-20 |
Alpine Immune Sciences, Inc. |
Icos ligand variant immunomodulatory proteins and uses thereof
|
|
US11471488B2
(en)
|
2016-07-28 |
2022-10-18 |
Alpine Immune Sciences, Inc. |
CD155 variant immunomodulatory proteins and uses thereof
|
|
CA3032120A1
(en)
|
2016-07-28 |
2018-02-01 |
Alpine Immune Sciences, Inc. |
Cd155 variant immunomodulatory proteins and uses thereof
|
|
US11834490B2
(en)
|
2016-07-28 |
2023-12-05 |
Alpine Immune Sciences, Inc. |
CD112 variant immunomodulatory proteins and uses thereof
|
|
KR20190099194A
(en)
|
2016-10-20 |
2019-08-26 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
Secretory variant immunomodulatory proteins and engineered cell therapy
|
|
CA3052473A1
(en)
|
2017-02-09 |
2018-08-16 |
Indapta Therapeutics, Inc. |
Engineered natural killer (nk) cells and compositions and methods thereof
|
|
EP3596115A1
(en)
|
2017-03-16 |
2020-01-22 |
Alpine Immune Sciences, Inc. |
Pd-l2 variant immunomodulatory proteins and uses thereof
|
|
BR112019018747A2
(en)
|
2017-03-16 |
2020-05-05 |
Alpine Immune Sciences Inc |
variant immunomodulatory proteins of cd80 and uses thereof
|
|
FI3596116T3
(en)
|
2017-03-16 |
2023-11-09 |
Alpine Immune Sciences Inc |
Pd-l1 variant immunomodulatory proteins and uses thereof
|
|
WO2018191654A1
(en)
|
2017-04-14 |
2018-10-18 |
Cold Genesys, Inc. |
Methods of treating bladder cancer
|
|
KR20230020022A
(en)
|
2017-10-10 |
2023-02-09 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
Ctla-4 variant immunomodulatory proteins and uses thereof
|
|
AU2018351000B2
(en)
|
2017-10-18 |
2023-11-30 |
Alpine Immune Sciences, Inc. |
Variant ICOS Ligand immunomodulatory proteins and related compositions and methods
|
|
BR112020013236A2
(en)
|
2018-01-03 |
2020-12-01 |
Alpine Immune Sciences, Inc. |
immunomodulatory proteins from multiple domains and methods of their use
|
|
US20210363219A1
(en)
|
2018-06-15 |
2021-11-25 |
Alpine Immune Sciences, Inc. |
Pd-1 variant immunomodulatory proteins and uses thereof
|
|
EP3884041A2
(en)
|
2018-11-21 |
2021-09-29 |
Indapta Therapeutics, Inc. |
Methods for expansion of natural killer (nk) cell subset and related compositions and methods
|
|
TW202038947A
(en)
|
2018-11-28 |
2020-11-01 |
德商創新分子有限責任公司 |
Helicase primase inhibitors for treating cancer in a combination therapy with oncolytic viruses
|
|
US20220372106A1
(en)
|
2018-11-30 |
2022-11-24 |
Alpine Immune Sciences, Inc. |
Cd86 variant immunomodulatory proteins and uses thereof
|
|
US20230190801A1
(en)
|
2020-04-22 |
2023-06-22 |
Indapta Therapeutics, Inc. |
Natural killer (nk) cell compositions and methods for generating same
|
|
CN111850126B
(en)
*
|
2020-08-06 |
2022-11-01 |
北京市神经外科研究所 |
Application of oncolytic virus in treatment of uveal melanoma, marker of treatment effect and detection reagent thereof
|